Metabolic Syndrome Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer

PURPOSE: This research investigated the predictive role of metabolic syndrome (MetS) in breast cancer neoadjuvant chemotherapy (BCNACT) response. METHODS: One hundred fifty primary breast cancer (BC) patients who underwent neoadjuvant chemotherapy (NACT) were included retrospectively. MetS, MetS com...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Ying, Wang, Pinxiu, Lan, Ning, Kong, Fei, Abdumijit, Awaguli, Tu, Shiyan, Li, Yanting, Yuan, Wenzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284232/
https://www.ncbi.nlm.nih.gov/pubmed/35847887
http://dx.doi.org/10.3389/fonc.2022.899335